Live Chimeric and Inactivated Japanese Encephalitis Virus Vaccines Differ in Their Cross-Protective Values against Murray Valley Encephalitis Virus

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Virology

• Publication date

  2008-12-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.02273-08PMID 19109382PMCID PMC2648276
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Current use and development of vaccines for Japanese encephalitis

  2008cited by this paper
• The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus.

  2008cited by this paper
• In situ reactions of monoclonal antibodies with a viable mutant of Murray Valley encephalitis virus reveal an absence of dimeric NS1 protein.

  2007cited by this paper
• Murray Valley encephalitis in an adult traveller complicated by long-term flaccid paralysis: case report and review of the literature.

  2007cited by this paper
• Previous infection with West Nile or St. Louis encephalitis viruses provides cross protection during reinfection in house finches.

  2006cited by this paper
• Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity

  2006cited by this paper
• Arboviruses causing human disease in the Australasian zoogeographic region

  2005cited by this paper
• The suitability of yellow fever and Japanese encephalitis vaccines for immunization against West Nile virus.

  2005cited by this paper
• Alpha/Beta Interferon Protects against Lethal West Nile Virus Infection by Restricting Cellular Tropism and Enhancing Neuronal Survival

  2005cited by this paper
• Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004.

  2005cited by this paper
• Common E Protein Determinants for Attenuation of Glycosaminoglycan-Binding Variants of Japanese Encephalitis and West Nile Viruses

  2004cited by this paper
• Neutralization and antibody-dependent enhancement of dengue viruses.

  2003cited by this paper
• Cross-protective and infection-enhancing immunity in mice vaccinated against flaviviruses belonging to the Japanese encephalitis virus serocomplex.

  2003cited by this paper
• CD8+ T Cells Mediate Recovery andImmunopathology in West Nile VirusEncephalitis

  2003cited by this paper
• Partial protective effect of inactivated Japanese encephalitis vaccine on lethal West Nile virus infection in mice.

  2003cited by this paper
• Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.

  2003cited by this paper
• Clinical and laboratory findings on the first imported case of Murray Valley encephalitis in Europe.

  2003cited by this paper
• Role of type I and type II interferon responses in recovery from infection with an encephalitic flavivirus.

  2003cited by this paper
• Antibody-dependent enhancement of Murray Valley encephalitis virus virulence in mice.

  2003cited by this paper
• Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections.

  2002cited by this paper
• Lack of both Fas Ligand and Perforin Protects from Flavivirus-Mediated Encephalitis in Mice

  2002cited by this paper
• Short report: absence of protective neutralizng antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines.

  2002cited by this paper
• Japanese encephalitis vaccines: current vaccines and future prospects.

  2002cited by this paper
• Ratios of subclinical to clinical Japanese encephalitis (JE) virus infections in vaccinated populations: evaluation of an inactivated JE vaccine by comparing the ratios with those in unvaccinated populations.

  2002cited by this paper
• Editorial: jennerian vaccination against West Nile virus.

  2002cited by this paper
• Mechanism of Virulence Attenuation of Glycosaminoglycan-Binding Variants of Japanese Encephalitis Virus and Murray Valley Encephalitis Virus

  2002cited by this paper
• Immunization with Heterologous Flaviviruses Protective Against Fatal West Nile Encephalitis

  2002cited by this paper
• Construction, Safety, and Immunogenicity in Nonhuman Primates of a Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine

  2001cited by this paper
• Antibody to the nonstructural protein NS1 of Japanese encephalitis virus: potential application of mAb-based indirect ELISA to differentiate infection from vaccination.

  2001cited by this paper
• Experimental infections of pigs with Japanese encephalitis virus and closely related Australian flaviviruses.

  2001cited by this paper
• Immunisation with gamma globulin to Murray Valley encephalitis virus and with an inactivated Japanese encephalitis virus vaccine as prophylaxis against Australian encephalitis: Evaluation in a mouse model

  2000cited by this paper
• Chimeric Yellow Fever Virus 17D-Japanese Encephalitis Virus Vaccine: Dose-Response Effectiveness and Extended Safety Testing in Rhesus Monkeys

  2000cited by this paper
• Arboviruses associated with human disease in Australia.

  2000cited by this paper
• Japanese encephalitis in north Queensland, Australia, 1998

  1999cited by this paper
• Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.

  1999influential reference
• DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus.

  1998cited by this paper
• Australian encephalitis in Western Australia

  1997cited by this paper
• Isolation of Japanese encephalitis virus from Culex annulirostris in Australia.

  1997cited by this paper
• An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995

  1996cited by this paper
• Protective immune responses to the E and NS1 proteins of Murray Valley encephalitis virus in hybrids of flavivirus-resistant mice.

  1996cited by this paper
• Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors

  1995cited by this paper
• Functional role of type I and type II interferons in antiviral defense.

  1994cited by this paper
• Australian Encephalitis in Western Australia, 1978–1991

  1993cited by this paper
• Two-way cross-protection between West Nile and Japanese encephalitis viruses in bonnet macaques.

  1992cited by this paper
• Two-way cross-protection between West Nile and Japanese encephalitis viruses in bonnet macaques.

  1992cited by this paper
• Antibody-dependent enhancement of yellow fever and Japanese encephalitis virus neurovirulence.

  1989cited by this paper
• Protection against Japanese encephalitis by inactivated vaccines.

  1988cited by this paper
• Antibody-mediated early death in vivo after infection with yellow fever virus.

  1986cited by this paper
• Antibody-dependent plaque enhancement: its antigenic specificity in relation to Togaviridae.

  1982cited by this paper
• Immune enhancement of viral infection.

  1982cited by this paper
• ENHANCEMENT OF THE INFECTIVITY OF ARBOVIRUSES BY SPECIFIC ANTISERA PRODUCED IN DOMESTIC FOWLS.

  1964cited by this paper
• Immunity of Hamsters to West Nile and Murray Valley Viruses Following Immunization with St. Louis and Japanese B.∗

  1956cited by this paper

• Pre-existing YFV-17D immunity mediates T cell cross-protection against dengue virus serotype 2 infection in mice

  2025cites this paper
• Synthetic rational design of live-attenuated Zika viruses based on a computational model

  2025cites this paper
• Development of Langat virus infectious clones as a platform for live-attenuated tick-borne encephalitis vaccine

  2025cites this paper
• Characterisation of a Japanese Encephalitis virus genotype 4 isolate from the 2022 Australian outbreak

  2024cites this paper
• A chimeric vaccine derived from Australian genotype IV Japanese encephalitis virus protects mice from lethal challenge

  2024cites this paper
• A Perspective on Current Flavivirus Vaccine Development: A Brief Review

  2023influential citation
• An integrated public health response to an outbreak of Murray Valley encephalitis virus infection during the 2022–2023 mosquito season in Victoria

  2023cites this paper
• Japanese encephalitis disease: overview of the virus, its risk to Australia and the need for better surveillance

  2022cites this paper
• The Japanese Encephalitis Antigenic Complex Viruses: From Structure to Immunity

  2022cites this paper
• Japanese Encephalitis Virus: The Emergence of Genotype IV in Australia and Its Potential Endemicity

  2022cites this paper
• An Advax-Adjuvanted Inactivated Cell-Culture Derived Japanese Encephalitis Vaccine Induces Broadly Neutralising Anti-Flavivirus Antibodies, Robust Cellular Immunity and Provides Single Dose Protection

  2021cites this paper
• Murray Valley Encephalitis Virus

  2021cites this paper
• An Advax-adjuvanted Inactivated Cell-culture Japanese Encephalitis Vaccine Induces Broadly Neutralising Anti-flavivirus Antibodies and T-cell Immunity and Provides Single Dose Protection

  2021influential citation
• A replication-defective Japanese encephalitis virus (JEV) vaccine candidate with NS1 deletion confers dual protection against JEV and West Nile virus in mice

  2020cites this paper
• Mosquito Cell-Derived Japanese Encephalitis Virus-Like Particles Induce Specific Humoral and Cellular Immune Responses in Mice

  2020cites this paper
• A replication-defective Japanese encephalitis virus (JEV) vaccine candidate with NS1 deletion confers dual protection against JEV and West Nile virus in mice

  2020cites this paper
• Japanese encephalitis virus prM-E antigen immunization conferred protection against challenge by four different serotypes of Dengue viruses in mice

  2019cites this paper
• Recent developments in vaccines and biological therapies against Japanese encephalitis virus

  2018cites this paper
• Flavivirus serocomplex cross-reactive immunity is protective by activating heterologous memory CD4 T cells

  2018cites this paper
• 33 – Japanese Encephalitis Vaccines

  2018cites this paper
• Mosquito assemblages associated with urban water bodies; implications for pest and public health threats

  2017cites this paper
• Partial dysfunction of STAT1 profoundly reduces host resistance to flaviviral infection.

  2017cites this paper
• 16 Immunobiology of Japanese Encephalitis Virus

  2017cites this paper
• Zika beyond the Americas: Travelers as sentinels of Zika virus transmission. A GeoSentinel analysis, 2012 to 2016.

  2017cites this paper
• Sydney's Mosquitoes: Their role as disease vectors

  2015cites this paper
• Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessment.

  2015cites this paper
• Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals

  2014cites this paper
• Protection of a Single Dose West Nile Virus Recombinant Subviral Particle Vaccine against Lineage 1 or 2 Strains and Analysis of the Cross-Reactivity with Usutu Virus

  2014cites this paper
• ive virus vaccines based on a yellow fever vaccine backbone : tandardized template with key considerations for a risk / benefit

  2014cites this paper
• Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus

  2014cites this paper
• The Changing Epidemiology of Murray Valley Encephalitis in Australia: The 2011 Outbreak and a Review of the Literature

  2014cites this paper
• Flaviviruses : Yellow Fever, Japanese B, West Nile, and Others

  2014cites this paper
• Antibodyand Pre-Exposure Neutralizing T + Memory B Cells in the Absence of CD8 Japanese Encephalitis Virus Mediated by JE-ADVAX Vaccine Protection against

  2014cites this paper
• Prime-Boost Immunization Strategies against Chikungunya Virus

  2014cites this paper
• Flaviviruses in Europe: Complex Circulation Patterns and Their Consequences for the Diagnosis and Control of West Nile Disease

  2013influential citation
• Substrate-based peptidomimetic inhibitors of the Murray Valley encephalitis virus NS2B/NS3 serine protease: a P1-P4 SAR study.

  2013cites this paper
• The role of genetic diversity in the replication, pathogenicity and virulence of Murray Valley encephalitis virus

  2013cites this paper
• 19 – Japanese encephalitis vaccines

  2013cites this paper
• JE-ADVAX™ Vaccine Protection against Japanese Encephalitis

  2013cites this paper
• JE-ADVAX Vaccine Protection against Japanese Encephalitis Virus Mediated by Memory B Cells in the Absence of CD8+ T Cells and Pre-Exposure Neutralizing Antibody

  2013cites this paper
• An Inactivated Cell Culture Japanese Encephalitis Vaccine (JE-ADVAX) Formulated with Delta Inulin Adjuvant Provides Robust Heterologous Protection against West Nile Encephalitis via Cross-Protective Memory B Cells and Neutralizing Antibody

  2013cites this paper
• Primary and Secondary Immune Responses During Sequential West Nile Virus and Japanese Encephalitis Virus Infections: A Dissertation

  2012cites this paper
• Clinical development of IMOJEV®—a recombinant Japanese encephalitis chimeric vaccine (JE-CV)

  2012influential citation
• 1 Encephalitic Flaviviruses

  2012cites this paper
• Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex

  2012cites this paper
• Murray Valley encephalitis: a review of clinical features, diagnosis and treatment

  2012cites this paper
• Immunobiology of Japanese Encephalitis Virus

  2011cites this paper
• Flavivirus-induced antibody cross-reactivity

  2011influential citation
• Pathogenesis of Japanese encephalitis virus infection in a golden hamster model and evaluation of flavivirus cross-protective immunity.

  2011cites this paper
• Preexisting Japanese Encephalitis Virus Neutralizing Antibodies and Increased Symptomatic Dengue Illness in a School-Based Cohort in Thailand

  2011cites this paper
• Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus.

  2011cites this paper
• Evaluation of an inactivated Ross River virus vaccine in active and passive mouse immunization models and establishment of a correlate of protection.

  2011cites this paper
• The viruses of Australia and the risk to tourists.

  2011cites this paper
• Recombinant, Chimeric, Live, Attenuated Vaccines Against Flaviviruses and Alphaviruses

  2011cites this paper
• Japanese encephalitis: update on vaccines and vaccine recommendations

  2010cites this paper
• Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.

  2010cites this paper
• IMOJEV®: a Yellow fever virus-based novel Japanese encephalitis vaccine

  2010cites this paper
• An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses

  2010cites this paper
• Biochemical characterisation of Murray Valley encephalitis virus proteinase

  2010cites this paper
• Arthropod-Borne Flaviviruses

  2009cites this paper
• Japanese encephalitis: is there a need for a novel vaccine?

  2009cites this paper
• International Journal of General Medicine Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Development of a Vaccine to Prevent Japanese Encephalitis: a Brief Review

  year unknowncites this paper